Ryan Zimmerman
Stock Analyst at BTIG
(4.01)
# 1,788
Out of 4,675 analysts
1396
Total ratings
48.2%
Success rate
5%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Rated: Buy | $193 → $202 | $184.89 | +9.25% | 83 | Aug 20, 2026 | |
| KIDS OrthoPediatrics | Rated: Buy | $24 → $29 | $25.65 | +13.06% | 71 | Aug 20, 2026 | |
| LNSR LENSAR | Rated: Buy | $7 → $10 | $8.68 | +15.21% | 24 | Aug 20, 2026 | |
| RCEL AVITA Medical | Maintained: Buy | $7 → $11 | $10.06 | +9.34% | 57 | Aug 19, 2026 | |
| GEHC GE HealthCare Technologies | Maintained: Buy | $79 | $74.82 | +5.59% | 42 | Aug 19, 2026 | |
| TCMD Tactile Systems Technology | Maintained: Buy | $40 → $39 | $23.82 | +63.73% | 49 | Aug 11, 2026 | |
| GMED Globus Medical | Maintained: Hold | n/a | $86.91 | - | 75 | Aug 7, 2026 | |
| ORGO Organogenesis Holdings | Maintained: Hold | n/a | $1.80 | - | 66 | Aug 7, 2026 | |
| SI Shoulder Innovations | Reiterated: Buy | $24 → $26 | $22.06 | +17.86% | 6 | Aug 7, 2026 | |
| RXST RxSight | Maintained: Hold | n/a | $6.25 | - | 41 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 → $95 | $89.57 | +6.06% | 21 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $16.05 | +43.30% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $21.68 | - | 31 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $371 → $358 | $329.45 | +8.67% | 82 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $0.6422 | +211.43% | 34 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $100.98 | - | 67 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $512 → $469 | $378.81 | +23.81% | 64 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $23.14 | - | 55 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $90 → $91 | $93.35 | -2.52% | 50 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $325.18 | - | 59 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $26.06 | +49.65% | 6 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.74 | - | 62 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $10.61 | +79.08% | 2 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $4 | $1.60 | +150.00% | 13 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $42.68 | - | 83 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 → $1 | $0.3249 | +207.79% | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 73.62 | CHF 58.80 | +25.20% | 64 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.04 | - | 23 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.34 | - | 31 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.01 | n/a | 36 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $132 | $128.52 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $50.40 | n/a | 31 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $350 | $148.16 | n/a | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $348.37 | n/a | 1 | Apr 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.21 | n/a | 19 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.52 | n/a | 12 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $116.64 | n/a | 2 | Aug 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.39 | n/a | 10 | Dec 24, 2018 |
Glaukos
Aug 20, 2026
Rated: Buy
Price Target: $193 → $202
Current: $184.89
Upside: +9.25%
OrthoPediatrics
Aug 20, 2026
Rated: Buy
Price Target: $24 → $29
Current: $25.65
Upside: +13.06%
LENSAR
Aug 20, 2026
Rated: Buy
Price Target: $7 → $10
Current: $8.68
Upside: +15.21%
AVITA Medical
Aug 19, 2026
Maintained: Buy
Price Target: $7 → $11
Current: $10.06
Upside: +9.34%
GE HealthCare Technologies
Aug 19, 2026
Maintained: Buy
Price Target: $79
Current: $74.82
Upside: +5.59%
Tactile Systems Technology
Aug 11, 2026
Maintained: Buy
Price Target: $40 → $39
Current: $23.82
Upside: +63.73%
Globus Medical
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $86.91
Upside: -
Organogenesis Holdings
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $1.80
Upside: -
Shoulder Innovations
Aug 7, 2026
Reiterated: Buy
Price Target: $24 → $26
Current: $22.06
Upside: +17.86%
RxSight
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $6.25
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $91 → $95
Current: $89.57
Upside: +6.06%
Aug 6, 2026
Reiterated: Buy
Price Target: $23
Current: $16.05
Upside: +43.30%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $21.68
Upside: -
Jul 31, 2026
Maintained: Buy
Price Target: $371 → $358
Current: $329.45
Upside: +8.67%
Jul 28, 2026
Maintained: Buy
Price Target: $2
Current: $0.6422
Upside: +211.43%
Jul 23, 2026
Maintained: Hold
Price Target: n/a
Current: $100.98
Upside: -
Jul 17, 2026
Maintained: Buy
Price Target: $512 → $469
Current: $378.81
Upside: +23.81%
Jul 16, 2026
Maintained: Hold
Price Target: n/a
Current: $23.14
Upside: -
Jul 13, 2026
Rated: Buy
Price Target: $90 → $91
Current: $93.35
Upside: -2.52%
Jul 10, 2026
Maintained: Hold
Price Target: n/a
Current: $325.18
Upside: -
Jul 6, 2026
Maintained: Buy
Price Target: $39
Current: $26.06
Upside: +49.65%
Jun 22, 2026
Maintained: Hold
Price Target: n/a
Current: $16.74
Upside: -
Jun 22, 2026
Maintained: Buy
Price Target: $19
Current: $10.61
Upside: +79.08%
May 26, 2026
Maintained: Buy
Price Target: $3 → $4
Current: $1.60
Upside: +150.00%
Apr 5, 2026
Maintained: Hold
Price Target: n/a
Current: $42.68
Upside: -
Mar 31, 2026
Maintained: Buy
Price Target: $1.5 → $1
Current: $0.3249
Upside: +207.79%
Mar 23, 2026
Maintained: Buy
Price Target: CHF 73.62
Current: CHF 58.80
Upside: +25.20%
Nov 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.04
Upside: -
Nov 7, 2025
Downgraded: Hold
Price Target: n/a
Current: $4.34
Upside: -
Feb 25, 2025
Maintained: Hold
Price Target: n/a
Current: $10.01
Upside: n/a
Oct 16, 2023
Maintained: Buy
Price Target: $132
Current: $128.52
Upside: n/a
Aug 18, 2023
Rated: Hold
Price Target: n/a
Current: $50.40
Upside: n/a
Apr 17, 2023
Maintained: Buy
Price Target: $350
Current: $148.16
Upside: n/a
Apr 10, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $348.37
Upside: n/a
Oct 14, 2022
Rated: Hold
Price Target: n/a
Current: $13.21
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $10.52
Upside: n/a
Aug 27, 2020
Rated: Hold
Price Target: n/a
Current: $116.64
Upside: n/a
Dec 24, 2018
Maintained: Hold
Price Target: n/a
Current: $1.39
Upside: n/a